Shandong Xinhua Pharma Renews Trademark Licence with Hualu; Shares Down 3%

MT Newswires Live

10/27

Shandong Xinhua Pharmaceutical (HKG:0719, SHE:000756) said it has renewed its trademark licence agreement with Shandong Xinhua Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.

Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.

Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.

The agreement allows the company to continue using the "Xinhua" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2578774660"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2578774660\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2578774660?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-27 11:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2578774660","market":"hk","top_or_hot":-1,"title":"Shandong Xinhua Pharma Renews Trademark Licence with Hualu; Shares Down 3%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SXPHF\">Shandong Xinhua</a> Pharmaceutical (HKG:0719, SHE:000756) said it has renewed its trademark licence agreement with <a href=\"https://laohu8.com/S/000756\">Shandong Xinhua</a> Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.</p><p>Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.</p><p>Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.</p><p>The agreement allows the company to continue using the \"Xinhua\" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shandong Xinhua Pharma Renews Trademark Licence with Hualu; Shares Down 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShandong Xinhua Pharma Renews Trademark Licence with Hualu; Shares Down 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-10-27 11:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SXPHF\">Shandong Xinhua</a> Pharmaceutical (HKG:0719, SHE:000756) said it has renewed its trademark licence agreement with <a href=\"https://laohu8.com/S/000756\">Shandong Xinhua</a> Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.</p><p>Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.</p><p>Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.</p><p>The agreement allows the company to continue using the \"Xinhua\" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2578774660","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2578774660","pubTimestamp":1761535144,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shandong Xinhua Pharmaceutical  said it has renewed its trademark licence agreement with Shandong Xinhua Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.The agreement allows the company to continue using the \"Xinhua\" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","BK1515":"抗疫概念","00719":"山东新华制药股份","000756":"新华制药","BK0239":"医药制造","BK0164":"国企混改"},"translate_title":"山东新华制药与华录续签商标许可；股价下跌3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000756":0.9,"00719":0.9},"content_text":"Shandong Xinhua Pharmaceutical (HKG:0719, SHE:000756) said it has renewed its trademark licence agreement with Shandong Xinhua Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.The agreement allows the company to continue using the \"Xinhua\" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}